This Has Won 99.1% Of Trades Over 3 Years
Video reveals the most powerful trade you’ve NEVER heard of. Released every Tuesday, it could DOUBLE your money by Friday.

In past 3 years, it’s won 321 out of 324 of these trades, with the majority making 100%+ every 3-10 days.

See how a simple 10-minute trade on Tue could double your money by Fri.

Watch Video Now For Full Details.
>>>
Roland Goette, insider at Becton, Dickinson and

Roland Goette Insider Information

Roland Goette serves as executive vice president and president of the Europe, Middle East and Africa (EMEA) region for BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in Franklin Lakes, New Jersey. He is also a member of the BD Executive Leadership Team.

Goette joined BD in 2000 as European marketing manager for Flow Cytometry. He then was named to a number of roles with increasing responsibility, including serving as business director of the BD Biosciences business in Eastern Europe, Middle East and Africa, and as vice president (VP) and general manager (GM) of BD Medical Surgical Systems for Central and South Asia. In this role, he spent three years in Singapore, and then was named VP/GM of Medical Surgical Systems in Europe.

Goette earned a doctorate in chemistry from the Ludwig-Maximilians University in Munich.

What is Roland Goette's net worth?

The estimated net worth of Roland Goette is at least $2.54 million as of November 23rd, 2020. Mr. Goette owns 10,085 shares of Becton, Dickinson and stock worth more than $2,539,403 as of July 3rd. This net worth evaluation does not reflect any other assets that Mr. Goette may own. Learn More about Roland Goette's net worth.

How do I contact Roland Goette?

The corporate mailing address for Mr. Goette and other Becton, Dickinson and executives is 1 BECTON DRIVE, FRANKLIN LAKES NJ, 07417. Becton, Dickinson and can also be reached via phone at (201) 847-6800. Learn More on Roland Goette's contact information.

Has Roland Goette been buying or selling shares of Becton, Dickinson and?

Roland Goette has not been actively trading shares of Becton, Dickinson and over the course of the past ninety days. As far as recent transactions, 0 shares of the company's stock in a transaction on Sunday, July 3rd. Learn More on Roland Goette's trading history.

Who are Becton, Dickinson and's active insiders?

Becton, Dickinson and's insider roster includes Simon Campion (EVP), Alexandre Conroy (EVP), Claire Fraser (Director), Roland Goette (EVP), David Hickey (EVP), Patrick Kaltenbach (EVP), Samrat Khichi (EVP), Betty Larson (EVP), James Lim (EVP), Thomas Polen, Jr. (Insider), Rebecca Rimel (Director), and Thomas Spoerel (VP). Learn More on Becton, Dickinson and's active insiders.

Are insiders buying or selling shares of Becton, Dickinson and?

During the last year, insiders at the medical instruments supplier sold shares 15 times. They sold a total of 35,210 shares worth more than $9,346,078.60. The most recent insider tranaction occured on June, 7th when VP Thomas J Spoerel sold 443 shares worth more than $115,180.00. Insiders at Becton, Dickinson and own 0.5 % of the company. Learn More about insider trades at Becton, Dickinson and.

Information on this page was last updated on 6/7/2022.

Roland Goette Insider Trading History at Becton, Dickinson and

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/23/2020Sell930$230.10$213,993.0010,085View SEC Filing Icon  
8/8/2019Sell1,717$249.88$429,043.9619,966View SEC Filing Icon  
See Full Table

Roland Goette Buying and Selling Activity at Becton, Dickinson and

This chart shows Roland Goette's buying and selling at Becton, Dickinson and by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Becton, Dickinson and Company Overview

Becton, Dickinson and logo
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Read More

Today's Range

Now: $251.80
Low: $244.32
High: $252.17

50 Day Range

MA: $249.80
Low: $234.74
High: $259.64

2 Week Range

Now: $251.80
Low: $231.46
High: $280.62

Volume

774,915 shs

Average Volume

1,101,136 shs

Market Capitalization

$71.78 billion

P/E Ratio

39.72

Dividend Yield

1.38%

Beta

0.62
This Options Expert is Giving Everything Away!
Trading champion Chuck Hughes has exposed the strategies of successful traders and handing them over to new traders like you!

His guide “Options Trading Made Easy” now comes with a Trade of the Day from Chuck himself to help you develop a profitable, pro-level trading account!
Get your copy today!